We are live on
!
Find out more
Insmed
INSM
INSM
252 hedge funds and large institutions have $3.72B invested in Insmed in 2023 Q3 according to their latest regulatory filings, with 50 funds opening new positions, 85 increasing their positions, 76 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
163% more first-time investments, than exits
New positions opened: 50 | Existing positions closed: 19
75% more funds holding in top 10
Funds holding in top 10: 4 → 7 (+3)
21% more capital invested
Capital invested by funds: $3.09B → $3.72B (+$634M)
13% more funds holding
Funds holding: 223 → 252 (+29)
12% more repeat investments, than reductions
Existing positions increased: 85 | Existing positions reduced: 76
4.83% less ownership
Funds ownership: 107.32% → 102.49% (-4.8%)
78% less call options, than puts
Call options by funds: $9.28M | Put options by funds: $42.5M
Holders
252
Holders Change
+29
Holders Change %
+13%
% of All Funds
4%
Holding in Top 10
7
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+75%
% of All Funds
0.11%
New
50
Increased
85
Reduced
76
Closed
19
Calls
$9.28M
Puts
$42.5M
Net Calls
-$33.2M
Net Calls Change
-$24.4M
Top Buyers
| 1 |
Millennium Management
New York
|
+$47.7M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$23.4M |
| 3 |
OCA
Octagon Capital Advisors
New York
|
+$21M |
| 4 |
RI
RTW Investments
New York
|
+$19.8M |
| 5 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
+$17.6M |
